Filing Details

Accession Number:
0001638986-15-000002
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-12-23 08:38:54
Reporting Period:
2015-12-16
Filing Date:
2015-12-23
Accepted Time:
2015-12-23 08:38:54
Original Submission Date:
2015-12-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1626878 Xbiotech Inc. XBIT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1638986 Queena Han 8201 E Riverside Drive
Bldg 4 Ste 100
Austin TX 78744
Vp Finance / Hr No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2015-12-18 10,000 $0.72 10,000 No 4 M Direct
Common Shares Disposition 2015-12-18 7,700 $10.51 2,300 No 4 S Direct
Common Shares Disposition 2015-12-18 2,300 $11.06 0 No 4 S Direct
Common Shares Acquisiton 2015-12-21 10,000 $0.72 10,000 No 4 M Direct
Common Shares Disposition 2015-12-21 7,110 $10.11 2,890 No 4 S Direct
Common Shares Disposition 2015-12-21 2,890 $10.65 0 No 4 S Direct
Common Shares Acquisiton 2015-12-22 10,000 $0.72 10,000 No 4 M Direct
Common Shares Disposition 2015-12-22 10,000 $10.25 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Commom Shares Stock Option Disposition 2015-12-16 10,000 $0.00 10,000 $0.72
Commom Shares Stock Option Disposition 2015-12-21 10,000 $0.00 10,000 $0.72
Commom Shares Stock Option Disposition 2015-12-22 10,000 $0.00 10,000 $0.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
40,000 2007-12-10 2016-12-09 No 4 M Direct
30,000 2007-12-10 2016-12-09 No 4 M Direct
20,000 2007-12-10 2016-12-09 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $10.23 to $10.70. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  2. This transaction was executed in multiple trades at prices ranging from $10.76 to $11.33. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  3. This transaction was executed in multiple trades at prices ranging from $9.80 to $10.36. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  4. This transaction was executed in multiple trades at prices ranging from $10.39 to $10.97. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  5. This transaction was executed in multiple trades at prices ranging from $10.01 to $10.7359. The price reported reflects the weighted average sale price. The Reporting Person has provided to the Issuer and will provide to any shareholder of the Issuer, or to the SEC Staff, upon request, information regarding the number of shares sold at each price within the range.
  6. The stock option exercise price was CAD$1.00, which is equivalent of USD$0.72